Evidence map›Paper›PMID 37060512›Full record

ArticleArchives of osteoporosis2023

Prevalence and risk factors of osteoporosis and osteopenia among residents in Hubei province, China.

Lin Zhang, Xiaoying Luo, Hao Liu, Wei Zhu, Xupeng Zhang, Shijie Zhu, Xiaowei Zhang, Gaichan Zhao, Tianzhou Li, Fengyu Xiao and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of osteoporosis, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Onion (International journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lin ZhangDepartment of Orthopaedics, Wuhan Hospital of Traditional Chinese and Western Medicine, Wuhan, 430022, China.
Xiaoying LuoDepartment of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, 430071, China.
Hao LiuInstitute of Chronic Disease Prevention and Cure, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China.
Wei ZhuDepartment of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, 430071, China.
Xupeng ZhangDepartment of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, 430071, China.
Shijie ZhuDepartment of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, 430071, China.
Xiaowei ZhangDepartment of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, 430071, China.
Gaichan ZhaoDepartment of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, 430071, China.
Tianzhou LiDepartment of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, 430071, China.
Fengyu XiaoDepartment of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, 430071, China.
Faxue ZhangDepartment of Occupational and Environmental Health, School of Public Health, Wuhan University, Wuhan, 430071, China. zhangfaxue@whu.edu.cn.
Fang ZhouInstitute of Chronic Disease Prevention and Cure, Hubei Provincial Center for Disease Control and Prevention, Wuhan, 430079, China. zhoufang2022@163.com.
Yanluan WanThe Ganyu District People's Hospital of Lianyungang City, Lianyungang, 222199, China. wan2716@126.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is the first time to estimate the prevalence and characterize of osteoporosis in Hubei province, China. The prevalence of osteoporosis was 12.19%, 3.69% for males, and 18.94% for females; 56.6% were diagnosed with osteopenia, 44.96% for males, and 65.84% for females.

introductionThe disease burden of osteoporosis is increasing, but there are few studies on the prevalence and risk factors in Hubei, China. This study aims to analyze the prevalence of osteoporosis using dual-energy X-ray absorptiometry (DXA) measurement and the risk factors of osteoporosis using epidemiological survey methods.

objectiveTo explore the prevalence of osteoporosis and osteopenia in Hubei province, and provide the epidemiological basis for policymakers, to reduce the prevalence of osteoporosis

methodsBased on data derived from the epidemiological survey of osteoporosis in Hubei province in 2018, 1592 residents aged 40 and above from 32 neighborhood committees/villages in 4 districts/counties of Hubei province were selected by multistage stratified random sampling. The lumbar spine AP (L1-L4 and L2-L4), femoral neck, and total hip BMD were measured using DXA of the internationally recognized gold standard and assessed according to WHO diagnostic criteria, utilizing unconditional logistic regression to explore the risk factors of osteoporosis and osteopenia.

resultsThe overall crude prevalence of osteoporosis was 12.19%, 3.69% for males, and 18.94% for females. Osteopenia was diagnosed in 56.6% of all participants, 44.96% in males, and 65.84% in females. Increasing age, females, and underweight were related to the high prevalence of osteoporosis and osteopenia, while people with higher levels of education, overweight, and obese had a low prevalence of osteoporosis and osteopenia. In women, the absence of chronic disease and moderate intake of dairy products probably be associated with the low prevalence of osteopenia.

conclusionsThe prevalence of osteoporosis and osteopenia is high in Hubei, China. The risk of prevalence of osteoporosis and osteopenia was higher in females and people with higher age and low BMI. While high BMI, high education, the absence of chronic disease, and intaking dairy moderately were negatively correlated with the prevalence of osteopenia or osteoporosis. The government should support the prevention and treatment of osteoporosis.

Indexed as

Bone Diseases, MetabolicOsteoporosisAbsorptiometry, PhotonBone DensityChinaFemaleHumansMalePrevalenceRisk FactorsBMIOsteopeniaOsteoporosisPrevalenceRisk factors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.